ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI

January 22, 1988

Drug Discovery Group Announcement Issued

January 7, 1983

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990